1. Li, Sisi, Huang, Xiao-Ting, Wang, Meng-Yao, Qi, Bin, Liu, Jin-Quan. 2021. FSCN1 Promotes Radiation Resistance in Patients With PIK3CA Gene Alteration. In Frontiers in oncology, 11, 653005. doi:10.3389/fonc.2021.653005. https://pubmed.ncbi.nlm.nih.gov/34249689/
2. Zernecke, Alma, Erhard, Florian, Weinberger, Tobias, Saliba, Antoine-Emmanuel, Cochain, Clément. . Integrated single-cell analysis-based classification of vascular mononuclear phagocytes in mouse and human atherosclerosis. In Cardiovascular research, 119, 1676-1689. doi:10.1093/cvr/cvac161. https://pubmed.ncbi.nlm.nih.gov/36190844/
3. Wang, Chao-Qun, Tang, Chih-Hsin, Wang, Yan, Zhao, Yong-Ming, Su, Chen-Ming. 2017. FSCN1 gene polymorphisms: biomarkers for the development and progression of breast cancer. In Scientific reports, 7, 15887. doi:10.1038/s41598-017-16196-6. https://pubmed.ncbi.nlm.nih.gov/29162880/
4. Mahdiannasser, Mojdeh, Haghpanah, Vahid, Damavandi, Elia, Larijani, Bagher, Ghadami, Mohsen. 2020. Investigation of promoter methylation of FSCN1 gene and FSCN1 protein expression in differentiated thyroid carcinomas. In Molecular biology reports, 47, 2161-2169. doi:10.1007/s11033-020-05315-8. https://pubmed.ncbi.nlm.nih.gov/32072403/
5. Chang, Dong, Liu, Xiang-Xiang, Liu, Rui, Sun, Jian-Wei. . The role and regulatory mechanism of FSCN1 in breast tumorigenesis and progression. In Yi chuan = Hereditas, 45, 115-127. doi:10.16288/j.yczz.22-346. https://pubmed.ncbi.nlm.nih.gov/36927659/
6. Chen, Cong, Xie, Bojian, Li, Zhaoqing, Xu, Ling, Wang, Linbo. 2022. Fascin enhances the vulnerability of breast cancer to erastin-induced ferroptosis. In Cell death & disease, 13, 150. doi:10.1038/s41419-022-04579-1. https://pubmed.ncbi.nlm.nih.gov/35165254/
7. Huang, Qingxia, Yao, Yao, Wang, Yisa, Zhao, Daqing, Li, Xiangyan. 2023. Ginsenoside Rb2 inhibits p300-mediated SF3A2 acetylation at lysine 10 to promote Fscn1 alternative splicing against myocardial ischemic/reperfusion injury. In Journal of advanced research, 65, 365-379. doi:10.1016/j.jare.2023.12.012. https://pubmed.ncbi.nlm.nih.gov/38101749/
8. Shi, Yueli, Xu, Yun, Xu, Zhiyong, Zheng, Shenfei, Wang, Kai. 2022. TKI resistant-based prognostic immune related gene signature in LUAD, in which FSCN1 contributes to tumor progression. In Cancer letters, 532, 215583. doi:10.1016/j.canlet.2022.215583. https://pubmed.ncbi.nlm.nih.gov/35149175/
智鼠故事 
